Why the study?
Does early discontinuation of aspirin therapy improve outcomes in patients with atrial fibrillation and acute coronary syndromes or PCI?
Does early discontinuation of aspirin therapy improve outcomes in patients with atrial fibrillation and acute coronary syndromes or PCI?
Answers are grounded in this paper and cite their sources.
Highlights the need for individualized assessment of competing risks when considering early discontinuation of aspirin in patients with AF and ACS/PCI.
An editorial focusing on the findings reported by Lopes et al. discusses early discontinuation of aspirin therapy after an acute coronary syndrome or PCI, recommending continued assessment of competing risks and avoidance of a one-size-fits-all policy.
No takes yet. Share an insight, caveat, or question.
Shamir R. Mehta (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: